531 related articles for article (PubMed ID: 31049579)
1. Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.
Pioner JM; Guan X; Klaiman JM; Racca AW; Pabon L; Muskheli V; Macadangdang J; Ferrantini C; Hoopmann MR; Moritz RL; Kim DH; Tesi C; Poggesi C; Murry CE; Childers MK; Mack DL; Regnier M
Cardiovasc Res; 2020 Feb; 116(2):368-382. PubMed ID: 31049579
[TBL] [Abstract][Full Text] [Related]
2. Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency.
Pioner JM; Santini L; Palandri C; Langione M; Grandinetti B; Querceto S; Martella D; Mazzantini C; Scellini B; Giammarino L; Lupi F; Mazzarotto F; Gowran A; Rovina D; Santoro R; Pompilio G; Tesi C; Parmeggiani C; Regnier M; Cerbai E; Mack DL; Poggesi C; Ferrantini C; Coppini R
Front Physiol; 2022; 13():1030920. PubMed ID: 36419836
[TBL] [Abstract][Full Text] [Related]
3. Generation of microRNA-378a-deficient hiPSC as a novel tool to study its role in human cardiomyocytes.
Martyniak A; Andrysiak K; Motais B; Coste S; Podkalicka P; Ferdek P; Stępniewski J; Dulak J
J Mol Cell Cardiol; 2021 Nov; 160():128-141. PubMed ID: 34329686
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients.
Eisen B; Ben Jehuda R; Cuttitta AJ; Mekies LN; Shemer Y; Baskin P; Reiter I; Willi L; Freimark D; Gherghiceanu M; Monserrat L; Scherr M; Hilfiker-Kleiner D; Arad M; Michele DE; Binah O
J Cell Mol Med; 2019 Mar; 23(3):2125-2135. PubMed ID: 30618214
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated iron homeostasis in dystrophin-deficient cardiomyocytes: correction by gene editing and pharmacological treatment.
Andrysiak K; Machaj G; Priesmann D; Woźnicka O; Martyniak A; Ylla G; Krüger M; Pyza E; Potulska-Chromik A; Kostera-Pruszczyk A; Łoboda A; Stępniewski J; Dulak J
Cardiovasc Res; 2024 Feb; 120(1):69-81. PubMed ID: 38078368
[TBL] [Abstract][Full Text] [Related]
6. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
Eisen B; Binah O
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240001
[TBL] [Abstract][Full Text] [Related]
7.
Jimenez-Vazquez EN; Arad M; Macías Á; Vera-Pedrosa ML; Cruz FM; Gutierrez LK; Cuttitta AJ; Monteiro da Rocha A; Herron TJ; Ponce-Balbuena D; Guerrero-Serna G; Binah O; Michele DE; Jalife J
Elife; 2022 Jun; 11():. PubMed ID: 35762211
[TBL] [Abstract][Full Text] [Related]
8. Depressed β-adrenergic inotropic responsiveness and intracellular calcium handling abnormalities in Duchenne Muscular Dystrophy patients' induced pluripotent stem cell-derived cardiomyocytes.
Mekies LN; Regev D; Eisen B; Fernandez-Gracia J; Baskin P; Ben Jehuda R; Shulman R; Reiter I; Palty R; Arad M; Gottlieb E; Binah O
J Cell Mol Med; 2021 Apr; 25(8):3922-3934. PubMed ID: 33619882
[TBL] [Abstract][Full Text] [Related]
9. Physiological stress improves stem cell modeling of dystrophic cardiomyopathy.
Fullenkamp DE; Willis AB; Curtin JL; Amaral AP; Dittloff KT; Harris SI; Chychula IA; Holgren CW; Burridge PW; Russell B; Demonbreun AR; McNally EM
Dis Model Mech; 2024 Jun; 17(6):. PubMed ID: 38050701
[TBL] [Abstract][Full Text] [Related]
10. Decreased YAP activity reduces proliferative ability in human induced pluripotent stem cell of duchenne muscular dystrophy derived cardiomyocytes.
Yasutake H; Lee JK; Hashimoto A; Masuyama K; Li J; Kuramoto Y; Higo S; Hikoso S; Hidaka K; Naito AT; Miyagawa S; Sawa Y; Komuro I; Sakata Y
Sci Rep; 2021 May; 11(1):10351. PubMed ID: 33990626
[TBL] [Abstract][Full Text] [Related]
11. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD
Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224
[TBL] [Abstract][Full Text] [Related]
12. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Mechanical Measurements of Myofibrils from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Pioner JM; Racca AW; Klaiman JM; Yang KC; Guan X; Pabon L; Muskheli V; Zaunbrecher R; Macadangdang J; Jeong MY; Mack DL; Childers MK; Kim DH; Tesi C; Poggesi C; Murry CE; Regnier M
Stem Cell Reports; 2016 Jun; 6(6):885-896. PubMed ID: 27161364
[TBL] [Abstract][Full Text] [Related]
14. IPSC derived cardiac fibroblasts of DMD patients show compromised actin microfilaments, metabolic shift and pro-fibrotic phenotype.
Soussi S; Savchenko L; Rovina D; Iacovoni JS; Gottinger A; Vialettes M; Pioner JM; Farini A; Mallia S; Rabino M; Pompilio G; Parini A; Lairez O; Gowran A; Pizzinat N
Biol Direct; 2023 Jul; 18(1):41. PubMed ID: 37501163
[TBL] [Abstract][Full Text] [Related]
15. Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy.
Duelen R; Costamagna D; Gilbert G; De Waele L; Goemans N; Desloovere K; Verfaillie CM; Sipido KR; Buyse GM; Sampaolesi M
Stem Cell Reports; 2022 Feb; 17(2):352-368. PubMed ID: 35090586
[TBL] [Abstract][Full Text] [Related]
16. Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.
Moretti A; Fonteyne L; Giesert F; Hoppmann P; Meier AB; Bozoglu T; Baehr A; Schneider CM; Sinnecker D; Klett K; Fröhlich T; Rahman FA; Haufe T; Sun S; Jurisch V; Kessler B; Hinkel R; Dirschinger R; Martens E; Jilek C; Graf A; Krebs S; Santamaria G; Kurome M; Zakhartchenko V; Campbell B; Voelse K; Wolf A; Ziegler T; Reichert S; Lee S; Flenkenthaler F; Dorn T; Jeremias I; Blum H; Dendorfer A; Schnieke A; Krause S; Walter MC; Klymiuk N; Laugwitz KL; Wolf E; Wurst W; Kupatt C
Nat Med; 2020 Feb; 26(2):207-214. PubMed ID: 31988462
[TBL] [Abstract][Full Text] [Related]
17. TRF2 rescues telomere attrition and prolongs cell survival in Duchenne muscular dystrophy cardiomyocytes derived from human iPSCs.
Eguchi A; Gonzalez AFGS; Torres-Bigio SI; Koleckar K; Birnbaum F; Zhang JZ; Wang VY; Wu JC; Artandi SE; Blau HM
Proc Natl Acad Sci U S A; 2023 Feb; 120(6):e2209967120. PubMed ID: 36719921
[TBL] [Abstract][Full Text] [Related]
18. Exon skipping and gene transfer restore dystrophin expression in human induced pluripotent stem cells-cardiomyocytes harboring DMD mutations.
Dick E; Kalra S; Anderson D; George V; Ritso M; Laval SH; Barresi R; Aartsma-Rus A; Lochmüller H; Denning C
Stem Cells Dev; 2013 Oct; 22(20):2714-24. PubMed ID: 23829870
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of intracellular Ca
Sato M; Shiba N; Miyazaki D; Shiba Y; Echigoya Y; Yokota T; Takizawa H; Aoki Y; Takeda S; Nakamura A
Biochem Biophys Res Commun; 2019 Nov; 520(1):179-185. PubMed ID: 31585729
[TBL] [Abstract][Full Text] [Related]
20. Targeted addition of mini-dystrophin into rDNA locus of Duchenne muscular dystrophy patient-derived iPSCs.
Zeng B; Zhou M; Liu B; Shen F; Xiao R; Su J; Hu Z; Zhang Y; Gu A; Wu L; Liu X; Liang D
Biochem Biophys Res Commun; 2021 Mar; 545():40-45. PubMed ID: 33540285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
